We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.74B
AUM Growth
+$95.7M
Cap. Flow
+$25.4M
Cap. Flow %
0.93%
Top 10 Hldgs %
40.58%
Holding
1,201
New
69
Increased
381
Reduced
653
Closed
98

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$12.1M
2
AAPL icon
Apple
AAPL
+$11.2M
3
MSFT icon
Microsoft
MSFT
+$11M
4
PLTR icon
Palantir
PLTR
+$9.36M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.79M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$17.2M
2
META icon
Meta Platforms (Facebook)
META
+$9.54M
3
TSLA icon
Tesla
TSLA
+$2.9M
4
XOM icon
ExxonMobil
XOM
+$2.23M
5
CVX icon
Chevron
CVX
+$1.87M

Sector Composition

Rank Sector Weight
1 Technology 44.82%
2 Consumer Discretionary 12.21%
3 Communication Services 10.56%
4 Healthcare 9.72%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
951
Crown Holdings
CCK
$12.8B
$224K 0.01%
2,706
-512
-16% -$46.6K
PKX icon
952
POSCO
PKX
$15.8B
$223K 0.01%
5,152
-3,176
-38% -$177K
AA icon
953
Alcoa
AA
$11.7B
$223K 0.01%
5,908
-643
-10% -$26.7K
CALM icon
954
Cal-Maine
CALM
$4.28B
$222K 0.01%
+2,159
New +$204K
ALB icon
955
Albemarle
ALB
$13.5B
$222K 0.01%
2,580
-729
-22% -$72.6K
AYI icon
956
Acuity Brands
AYI
$9.88B
$221K 0.01%
758
-76
-9% -$23.7K
PCRX icon
957
Pacira BioSciences
PCRX
$1.02B
$221K 0.01%
11,726
-5,985
-34% -$105K
FTDR icon
958
Frontdoor
FTDR
$5.02B
$221K 0.01%
+4,038
New +$219K
ALT icon
959
Altimmune
ALT
$539M
$220K 0.01%
30,550
-404
-1% -$3.09K
PEN icon
960
Penumbra
PEN
$12.5B
$220K 0.01%
926
-194
-17% -$44.1K
EG icon
961
Everest Group
EG
$15.2B
$219K 0.01%
603
-111
-16% -$41.6K
LDOS icon
962
Leidos
LDOS
$14.1B
$219K 0.01%
1,517
-211
-12% -$35.1K
IBP icon
963
Installed Building Products
IBP
$6.13B
$218K 0.01%
1,245
-12
-1% -$2.61K
LAD icon
964
Lithia Motors
LAD
$7.78B
$218K 0.01%
610
-67
-10% -$23.6K
CACI icon
965
CACI
CACI
$10.8B
$218K 0.01%
539
-56
-9% -$27.3K
DOC icon
966
Healthpeak Properties
DOC
$15.4B
$218K 0.01%
10,742
-8,983
-46% -$195K
ANNX icon
967
Annexon
ANNX
$855M
$217K 0.01%
42,273
+6,826
+19% +$42K
FUL icon
968
H.B. Fuller
FUL
$3B
$217K 0.01%
3,210
+376
+13% +$28.2K
BDC icon
969
Belden
BDC
$4B
$215K 0.01%
1,912
+31
+2% +$3.7K
CRC icon
970
California Resources
CRC
$4.75B
$215K 0.01%
+4,142
New +$225K
PCTY icon
971
Paylocity
PCTY
$6.71B
$215K 0.01%
1,077
-171
-14% -$32.7K
L icon
972
Loews
L
$24.3B
$215K 0.01%
2,534
-474
-16% -$39.1K
CGEM icon
973
Cullinan Oncology
CGEM
$1.05B
$215K 0.01%
17,619
-5,153
-23% -$74.1K
DG icon
974
Dollar General
DG
$25.9B
$214K 0.01%
2,822
-625
-18% -$49.3K
BTG icon
975
B2Gold
BTG
$5.16B
$214K 0.01%
87,665
-10,052
-10% -$29.5K

Similar funds

Profund Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Profund Advisors held 1,201 positions worth $2.74B, up 3.6% from $2.64B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors's Q4 2024 filing shows 69 new, 381 increased, 653 reduced and 98 closed positions. Its largest new stake was Applovin: 22,405 shares worth $7.26M. The largest sale was Broadcom, an estimated $17.2M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Profund Advisors's largest Q4 2024 buy was Applovin: 22,405 shares worth $7.26M.
  • Profund Advisors added most to Amazon in Q4 2024, an estimated $12.1M increase.
  • Profund Advisors's biggest Q4 2024 reduction was Broadcom, cutting an estimated $17.2M.
  • Profund Advisors fully exited Dollar Tree in Q4 2024, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 41% of its $2.74B portfolio in Q4 2024.
  • Profund Advisors opened 69 new positions and closed 98 in Q4 2024.
  • Profund Advisors's portfolio value rose 3.6% quarter-over-quarter to $2.74B.

Based on Profund Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.